Iradimed Co (IRMD)
Iradimed Co is a healthcare equipment company focused on products designed for use in magnetic resonance imaging (MRI) environments. Through its operating business, IRADIMED Corporation develops, manufactures, markets, and distributes MRI-compatible intravenous infusion pump systems, patient vital signs monitoring systems, and related accessories. Its product set includes the MRidium 3870 and 3860+ infusion pump systems, the 3880 MRI-compatible patient monitoring system, and the 3600 FMD1 ferromagnetic detection device with remote alarm logging functionality. The company also supplies non-magnetic IV poles, wireless remote displays and controls, side car pump modules, dose error reduction systems, and SpO2 monitoring components. IRADIMED serves hospitals, acute care facilities, and outpatient imaging centers, with sales supported by direct field representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and international markets. Incorporated in 1992, the company is headquartered in Orlando, Florida.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-IRMD
|
$69.35
|
-27.8% Downside
|
Overvalued
|
$118
|
22.9% Upside
|
Undervalued
|
Great
|
—
|
—
|
0.8
|
0.8%
|
July 30, 2026
|
52.2x
|
12.5x
|
14.3x
|
1.24 B
|
1.176 B
|
0.0%
|
65.1%
|
50.1
|
65.4%
|
103.7%
|